Construction and Characterization of Genetically Defined aro omp Mutants of Enterotoxigenic Escherichia coli and Preliminary Studies of Safety and Immunogenicity in Humans
Open Access
- 1 August 2001
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (8) , 4969-4979
- https://doi.org/10.1128/iai.69.8.4969-4979.2001
Abstract
Enterotoxigenic Escherichia coli (ETEC) is a leading cause of diarrhea in travelers to countries where the disease is endemic and causes a major disease burden in the indigenous population, particularly children. We describe here the generation and preclinical characterization of candidate strains of ETEC which are intended to provide the basis of a live attenuated oral vaccine to prevent this disease. It has been shown previously that a spontaneously arising toxin-negative variant ETEC strain, E1392/75-2A, could confer 75% protection against challenge when administered to volunteers. Unfortunately this strain induced mild diarrhea in 15% of recipients. To eliminate the unacceptable reactogenicity of strain E1392/75-2A, it was further attenuated by introducing three different combinations of defined deletion mutations into the chromosome. A mouse intranasal model of immunization was developed and used to show that all of the strains were immunogenic. Immune responses against colonization factor antigens (CFAs) were particularly strong when the bacterial inocula were grown on “CFA agar,” which induces strong expression of these antigens. Two of the strains were selected for a phase I dose escalation safety study with healthy adult volunteers. Freshly grown organisms were harvested from CFA agar plates and administered to volunteers as a suspension containing from 5 × 10 7 to 5 × 10 9 CFU. The vaccine was well tolerated at all doses and induced significant immune responses in all recipients at the highest dose of either strain. The results provide the basis for further clinical evaluation of these vaccine candidates.Keywords
This publication has 71 references indexed in Scilit:
- Phase 2 Clinical Trial of AttenuatedSalmonella entericaSerovar Typhi Oral Live Vector Vaccine CVD 908-htrAin U.S. VolunteersInfection and Immunity, 2000
- In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of AttenuatedSalmonella entericaSerovar Typhi Strains as Live Mucosal Vaccines and as Live VectorsInfection and Immunity, 2000
- Selective degradation of unfolded proteins by the self-compartmentalizing HtrA protease, a periplasmic heat shock protein in Escherichia coliJournal of Molecular Biology, 1999
- Role of the O-Antigen of Lipopolysaccharide, and Possible Roles of Growth Rate and of NADH:ubiquinone Oxidoreductase (nuo) in Competitive Tomato Root-Tip Colonization by Pseudomonas fluorescens WCS365Molecular Plant-Microbe Interactions®, 1998
- Protection of chickens against experimental fowl typhoid using a nuoG mutant of Salmonella serotype GallinarumVaccine, 1998
- Evaluation of Peru‐15, a New Live Oral Vaccine for Cholera, in VolunteersThe Journal of Infectious Diseases, 1997
- Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheresVaccine, 1994
- The role of a stress‐response protein in Salmonella typhimurium virulenceMolecular Microbiology, 1991
- A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative BacteriaBio/Technology, 1983
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981